CTI BioPharma Corp. (CTIC) was a big mover last session, as the company saw its shares rise nearly 12% on the day. The upside came after the company released data from a Phase 3 registration-directed trial that examined pacritinib to treat myleofibrosis.
Yahoo Finance · 1 day ago
CTI BioPharma
In-depth coverage >
CTI BioPharma Corp (NASDAQ:CTIC) along with its partner Baxter International Inc ... Meeting of the American Society of Clinical Oncology (ASCO) on Saturday. The stock started to surge after the announcement with … · 1 day ago
Altera Corp. (ALTR) traded at $51.75 + 1.88 (5.92 pct). The company is +12.96 pct during the past 30 days, +40.08 pct year-to-date, and +56.02 pct during the last 12 months. Bank of America Corp. (BAC) traded at …
Fx Pips · 1 day ago
More from Bing News
Roth Capital set a $4.50 target price on CTI BioPharma Corp (NASDAQ:CTIC) in a research note released on Monday morning. The firm currently has a a buy rating on the biopharmaceutical company’s stock. In other CTI BioPharma Corp news, EVP Jack W.
Mideast Times · 3 hours ago
Research analysts at Roth Capital set a $4.50 target price on shares of CTI BioPharma Corp (NASDAQ:CTIC) stock in a report released on Monday. The firm currently has a a “buy” rating on the biopharmaceutical company’s stock. Roth Capital’s …
Ticker Report · 6/1/2015
CTIC has traded 12.0 million shares today. CTIC is trading at 136.03 times the normal volume for the stock at this time of day. CTIC is trading at a new high 23.20% above yesterday's close. Portfolio Manager Jim Cramer and Director of Research Jack Mohr ...
The Street · 6/1/2015
... on updating investors with recent news on the U.S. stock market about the small and penny stocks, issues news alert on CTI BioPharma Corp. (NASDAQ:CTIC), OncothyreonInc (USA) (NASDAQ:ONTY), ImmunoGen, Inc. (NASDAQ:IMGN). CTI …
Market News Call · 1 day ago
CTI BioPharma Corp (NASDAQ:CTIC) EVP Jack W. Singer sold 15,000 shares of the company’s stock in a transaction that occurred on Friday, May 22nd. The stock was sold at an average price of $1.74, for a total value of $26,100.00. Following the … · 5/24/2015
Stocks were indicated higher on Monday after last week’s selling ... in a 52-week range of $5.51 to $7.56. CTI BioPharma Corp. (NASDAQ: CTIC) was reiterated as Buy with a fair value estimate of $3.50 (versus a $1.
24/7 Wall ST · 6/1/2015
What: Shares of CTI BioPharma Corp. (NASDAQ: CTIC ) were up more than 20% today after the company ... with other potential disease-modifying agents." Now what: CTI stock has put investors on a wild ride since coming public in 1997 and has lost badly ...
The Motley Fool · 6/1/2015
CTI Biopharma